TritiaReinaYamasakiMDPhD

PubMed

• Visualization of the Movement Disorder Society Unified Parkinson's Disease Rating Scale Results.
  Jaimie Hixson, Jorge E Quintero, Ashley Guiliani, Tritia R Yamasaki, Greg A Gerhardt, John T Slevin, Craig G van Horne> ;Journal of Parkinson's Disease. 2023 Jan 1
• 4 citations
  Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor.
  Elena A Ostrakhovitch, Eun-Suk Song, Jessica K A Macedo, Matthew S Gentry, Jorge E Quintero, Craig van Horne, Tritia R Yamasaki> ;Neuroscience Letters. 2022 Jan 19
• Gait and Balance Changes with Investigational Peripheral Nerve Cell Therapy during Deep Brain Stimulation in People with Parkinson's Disease.
  Geetanjali Gera, Zain Guduru, Tritia R. Yamasaki, Julie A. Gurwell, Monica Chau, Anna Krotinger, Frederick A. Schmitt, John T. Slevin, Greg A. Gerhardt, Craig G. van H...> ;Brain Sciences. 2021 Apr 15
• 14 citations
  Anti-aggregation Effects of Phenolic Compounds on α-synuclein
  Kenjiro Ono, Mayumi Tsuji, Tritia R. Yamasaki, Giulio Maria Pasinetti> ;Molecules. 2020 May 24
• 15 citations
  Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies.
  Tritia R. Yamasaki, Kenjiro Ono, Lap Ho, Giulio Maria Pasinetti> ;Frontiers in Neuroscience. 2020 May 4
• 131 citations
  Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
  Alberto J. Espay, Joaquin A. Vizcarra, Luca Marsili, Anthony E. Lang, David Simon, Aristide Merola, Keith A. Josephs, Alfonso Fasano, Francesca Morgante, Rodolfo Savic...> ;Neurology. 2019 Feb 12
• 111 citations
  Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics
  Tritia R. Yamasaki, Brandon B. Holmes, Jennifer L. Furman, Dhruva Dhavale, Bryant W. Su, Eun Suk Song, Nigel J. Cairns, Paul T. Kotzbauer, Marc I. Diamond> ;The Journal of Biological Chemistry. 2019 Jan 18
• 389 citations
  Proteopathic tau seeding predicts tauopathy in vivo
  Brandon B. Holmes, Jennifer L. Furman, Thomas E. Mahan, Tritia R. Yamasaki, Hilda Mirbaha, William C. Eades, Larisa Belaygorod, Nigel J. Cairns, David M. Holtzman, Mar...> ;Proceedings of the National Academy of Sciences of the United States of America. 2014 Oct 14
• 20 citations
  Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease.
  Edmond Teng, Tritia R. Yamasaki, Michelle Tran, Julia J. Hsiao, David L. Sultzer, Mario F. Mendez> ;Dementia and Geriatric Cognitive Disorders. 2014 Jan 1
• Variant lateral medullary syndrome in a patient presenting with inability to swallow.
  Neal M Rao, Tritia R. Yamasaki, Shri K. Mishra, Catherine Yim> ;The Neurohospitalist. 2013 Apr 1
• 603 citations
  Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.
  Mathew Blurton-Jones, Masashi Kitazawa, Hilda Martinez-Coria, Nicholas A. Castello, Franz-Josef Müller, Jeanne F. Loring, Tritia R. Yamasaki, Wayne W. Poon, Kim N. Gre...> ;Proceedings of the National Academy of Sciences of the United States of America. 2009 Aug 11
• 30 citations
  Activation of Cell Cycle Proteins in Transgenic Mice in Response to Neuronal Loss but not Amyloid-β and Tau Pathology
  João P. Lopes, Mathew Blurton-Jones, Tritia R. Yamasaki, Paula Agostinho, Frank M. LaFerla> ;Journal of Alzheimer's Disease. 2009 Jan 1
• 116 citations
  Neural Stem Cells Improve Memory in an Inducible Mouse Model of Neuronal Loss
  Tritia R. Yamasaki, Mathew Blurton-Jones, Debbi A. Morrissette, Masashi Kitazawa, Salvatore Oddo, Frank M. LaFerla> ;The Journal of Neuroscience. 2007 Oct 31
• 521 citations
  Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
  Masashi Kitazawa, Salvatore Oddo, Tritia R. Yamasaki, Kim N. Green, Frank M. LaFerla> ;The Journal of Neuroscience. 2005 Sep 28
• 98 citations
  Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau
  Masashi Kitazawa, Tritia R. Yamasaki, Frank M. LaFerla> ;Annals of the New York Academy of Sciences. 2004 Dec 1
• 89 citations
  Inclusion body myositis-like phenotype induced by transgenic overexpression of βAPP in skeletal muscle
  Michael C. Sugarman, Tritia R. Yamasaki, Salvatore Oddo, Julio C. Echegoyen, M. Paul Murphy, Todd E. Golde, Mehrdad Jannatipour, Malcolm A. Leissring, Frank M. LaFerla> ;Proceedings of the National Academy of Sciences of the United States of America. 2002 Apr 30
• 76 citations
  Calsenilin reverses presenilin-mediated enhancement of calcium signaling.
  Malcolm A. Leissring, Tritia R. Yamasaki, Wilma Wasco, Joseph D. Buxbaum, Ian Parker, Frank M. LaFerla> ;Proceedings of the National Academy of Sciences of the United States of America. 2000 Jul 18
• [A case of neuro-Behçet's disease presenting as chronic progressive cerebellar ataxia].
  Yamasaki T, Taniwaki T, Arakawa K, Yamada T, Kira J> ;Rinsho Shinkeigaku. 2000-03-01
• [A case of diabetic polyneuropathy complicated with entrapment neuropathy of the bilateral ulnar nerves due to osteoarthrosis at the elbow].
  Yamasaki T, Taniwaki T, Araki E, Arakawa K, Yamada T, Kira J> ;Rinsho Shinkeigaku. 2000-01-01
• [A case of congenital non-progressive cerebellar ataxia with pigmentary retinal degeneration, fiber type disproportion and hypercreatine kinasemia].
  Yamasaki T, Taniwaki T, Kikuchi H, Araki E, Arakawa K, Iwaki T, Yamada T, Kira J> ;Rinsho Shinkeigaku. 1999-09-01
• Ultrasonic bruits in the circle of Willis due to a large nonfunctioning pituitary adenoma.
  Nagai H, Moritake K, Nagao S, Yamasaki T> ;J Neuroimaging. 1997-10-01
• Extended survival with high quality of life in patients with primary intracerebral non-Hodgkin's lymphoma: report of four cases.
  Yamasaki T, Shima N, Yamabe H, Nagaoka S, Moritake K, Kikuchi H> ;Surg Neurol. 1995-01-01
• Chemotherapeutic effects of intra-arterial administration of ACNU in primary intracerebral non-Hodgkin's lymphoma.
  Yamasaki T, Kikuchi H, Shima N, Paine JT, Moritake K, Yamabe H> ;Surg Neurol. 1993-11-01
• Primary intracerebral malignant lymphoma associated with different histological types of carcinoma: report of two cases.
  Yamasaki T, Kikuchi H, Oda Y, Moritake K, Miura H, Shimada T> ;Surg Neurol. 1992-06-01
• Lesion of the nucleus basalis magnocellularis does not affect cerebral cortical blood flow in rats.
  Namba H, Irie T, Fukushi K, Yamasaki T, Tateno Y, Hasegawa S> ;Neurosci. Res.. 1991-11-01
• Join now to see all

Journal Articles

• Parkinson’s Disease and Multiple System Atrophy Have Distinct Α-synuclein Seed Characteristics  
  Brandon B. Holmes, Tritia R. Yamasaki, Marc I. Diamond, Nigel J. Cairns, Paul T. Kotzbauer, The Journal of Biological Chemistry
• Proteopathic tau seeding predicts tauopathy in vivo.  
  Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC, Belaygorod L, Cairns NJ, Holtzman DM, Diamond MI., Proc Natl Acad Sci U S A
• Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease.  
  Teng E, Yamasaki TR, Tran M, Hsiao JJ, Sultzer DL, Mendez MF., Dement Geriatr Cogn Disord, 12/2013
• Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.  
  Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM., Proc Natl Acad Sci U S A, 7/2009
• Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.  
  Lopes JP, Blurton-Jones M, Yamasaki TR, Agostinho P, LaFerla FM., J Alzheimers Dis, 2009
• Neural stem cells improve memory in an inducible mouse model of neuronal loss.  
  Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, LaFerla FM., J Neurosci., 10/2007
• Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.  
  Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM., J Neurosci, 9/2005
• Microglia as a potential bridge between the amyloid beta-peptide and tau.  
  Kitazawa M, Yamasaki TR, LaFerla FM., Ann N Y Acad Sci, 12/2004
• Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.  
  Sugarman MC, Yamasaki TR, Oddo S, Echegoyen JC, Murphy MP, Golde TE, Jannatipour M, Leissring MA, LaFerla FM., Proc Natl Acad Sci U S A., 4/2002
• Calsenilin reverses presenilin-mediated enhancement of calcium signaling.  
  Leissring MA, Yamasaki TR, Wasco W, Buxbaum JD, Parker I, LaFerla FM., Proc Natl Acad Sci U S A., 7/2000
• Join now to see all